Bayesian Capital Management, LP Compugen LTD Transaction History

Bayesian Capital Management, LP

  • $582 Million
  • Q1 2025

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$1.57 - $3.33 $28,652 - $60,772
-18,250 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$2.76 - $4.64 $50,369 - $84,680
18,250 New
18,250 $59,000
Q4 2020

Feb 12, 2021
SELL
$12.07 - $17.95 $123,645 - $183,879
-10,244 Closed
0 $0
Q3 2020

Nov 12, 2020
BUY
$14.16 - $19.45 $145,055 - $199,245
10,244 New
10,244 $166,000

Others Institutions Holding CGEN

# of Institutions
79
Shares Held
16.3M
Call Options Held
28.7K
Put Options Held
48.3K
View Full List

About COMPUGEN LTD

CGEN Quotes by TradingView
  • Ticker CGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,624,600
  • Market Cap $128M
  • Description
  • Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...
More about CGEN
Track This Portfolio

Track Bayesian Capital Management, LP Portfolio

Follow Bayesian Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bayesian Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email